A Phase I, Single-Center, Open-Label, Dose-Escalation Clinical Trial to Assess the Safety and Tolerability of an Intranasal Memory T Lymphocytes Solution in Adult Females: vRELEASE I. (vRELEASE I)

Clinical trial NCT06699758 · COMPLETED

Trial details

NCT number: NCT06699758
Sponsor: Cristina Calvo Rey
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

To Assess the Safety and Tolerability of Intranasal Administration of a Male Donor Memory T Lymphocyte Solution

Start date: 2025-02-05
Primary completion: 2025-07-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.